2019 UEM Edgenta Annual Report

210 Notes to the Financial Statements For the year ended 31 December 2019 18. INVESTMENT IN ASSOCIATES (CONT’D.) (ii) Summarised statements of comprehensive income Faber Sindoori Biomedix One Medicare Sedafiat Total 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 Revenue 107,604 100,432 52,130 48,003 196,597 186,022 243,000 227,322 599,331 561,779 Profit before tax 16,075 21,326 18,968 19,288 6,371 4,628 22,188 5,640 63,602 50,882 Profit for the year 11,570 13,812 14,584 14,659 5,138 3,518 16,822 4,170 48,114 36,159 Total comprehensive income 11,484 13,812 14,584 14,659 5,138 3,518 16,822 4,170 48,028 36,159 Dividend received from the associates during the year 986 - 2,400 4,000 1,200 - 1,200 2,400 5,786 6,400 (iii) Reconciliation of the summarised financial information presented above to the carrying amount of the Group’s interest in associates Faber Sindoori Biomedix One Medicare Sedafiat Total 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 2019 RM’000 2018 RM’000 Net assets at 1 January 45,801 31,989 26,906 22,247 30,091 26,573 32,663 34,493 135,461 115,302 Profit for the year 11,484 13,812 14,584 14,659 5,138 3,518 16,822 4,170 48,028 36,159 Dividend from associate (1,931) - (6,000) (10,000) (3,000) - (3,000) (6,000) (13,931) (16,000) Net assets at 31 December 55,354 45,801 35,490 26,906 32,229 30,091 46,485 32,663 169,558 135,461 Interest in associates 51% 51% 40% 40% 40% 40% 40% 40% Exchange differences (863) (864) - - - - - - (863) (864) Carrying value of Group’s interest in material associate 27,368 22,495 14,196 10,762 12,892 12,036 18,594 13,065 73,050 58,358